MEDIMMUNE, INC.

Basic Information

35 WEST WATKINS MILL RD
Gaithersburg, MD, 20878

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. CAPSOMERES AS BASIS FOR A HUMAN PAPILLOMAVIRUS VACCINE

    Amount: $99,986.00

    N/A

    SBIR Phase I 1998 Department of Health and Human Services
  2. LYME VACCINE BASED ON BORRELIA DECORIN ADHESIN

    Amount: $750,000.00

    N/A

    SBIR Phase II 1997 Department of Health and Human Services
  3. ADHESIN BASED VACCINE TO PREVENT URINARY TRACT INFECTION

    Amount: $748,501.00

    N/A

    SBIR Phase II 1997 Department of Health and Human Services
  4. LYME VACCINE BASED ON BORRELIA DECORIN ADHESIN

    Amount: $98,937.00

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  5. ADHESIN BASED VACCINE TO PREVENT URINARY TRACT INFECTION

    Amount: $99,969.00

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  6. LYME VACCINE BASED ON BORRELIA TRANSFERIN RECEPTORS

    Amount: $99,931.00

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  7. CD4 Based Therapeutic Vaccine for HIV

    Amount: $99,983.00

    An effective therapeutic vaccine for HIV should be capable of reducing viral load and spread of infprevent the onset of AIDS. In an SIV-rhesus macaque model, immunization with a recombinant, solubleCD ...

    SBIR Phase I 1995 Department of Health and Human Services
  8. Lyme Disease Vaccine Using Gonococcal Blebs

    Amount: $100,000.00

    The investigators will develop a system in which OspA, an antigen known to induce protective immuneagainst Borrelia burgdorferi, the causative agent of Lyme Disease, is cloned and exported to the outN ...

    SBIR Phase I 1995 Department of Health and Human Services
  9. Monoclonal Antibodies to Respiratory Syncytial Virus

    Amount: $81,000.00

    Respiratory syncytial virus (RSv) is the primary etiologic agent of pediatric respiratory tractinfection. In premature infants and children with bronchopulmonary dysplasia or congenital heartdisease, ...

    SBIR Phase I 1994 Department of Health and Human Services
  10. HUMAN-MURINE CHIMERIC ANTIBODIES VS. RESPIRATORY SYNCYTIAL VIRUS

    Amount: $428,150.00

    RESPIRATORY SYNCYTIAL VIRUS (RSV) IS RESPONSIBLE FOR YEARLY EPIDEMICS OF BRONCHIOLITIS AND PNEUMONIA IN INFANTS AND YOUNG CHILDREN. AT RISK OF SERIOUS RSV MORBIDITY ARE CHILDREN WITH UNDERLYING DISEAS ...

    SBIR Phase II 1993 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government